Clinical trialNCT02261051WithdrawnObservational

Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm

SponsorLancaster General HospitalEnrollment0Advanced CancerCancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Symptom Management, Quality of Life and Satisfaction with Care for Advanced Stage Cancers is the first part of a two part study (The Lancaster Cancer Care Model (LCCM) - Non-Concurrent Control Study). The primary aim of the study is to compare the proportion of advanced cancer patients who have a hospitalization or emergency department visit in the last 6 months of life before and after implementation of a new care model that provides more comprehensive symptom management and supportive care, including earlier referral to palliative care. The secondary comparative aim is to assess measures of quality of life and satisfaction in both groups. This current study is to collect data on the control group only. After system redesign, we will open an intervention arm study to collect data after implementation of the new care model (about 18-24 months from start of control phase).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Barbara Martin, PhD
Lancaster General Research Institute
Principal Investigator
clinicaltrials.gov ↗
Joan Harrold, MD
Palliative Medicine Consultants
Principal Investigator
clinicaltrials.gov ↗
Kristina Newport, MD
Palliative Medicine Consultants
Principal Investigator
clinicaltrials.gov ↗
Michael Horst, PhD
Lancaster General Research Institute
Principal Investigator
clinicaltrials.gov ↗
Nik Buescher
Lancaster General Ann B. Barshinger Cancer Institute
Principal Investigator
clinicaltrials.gov ↗
Randy Oyer, MD
Lancaster General Ann B. Barshinger Cancer Institute
Study Director
clinicaltrials.gov ↗
Shanthi Sivendran, MD, MSCR
Lancaster General Ann B. Barshinger Cancer Institute
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Lancaster General Ann B. Barshinger Cancer Institute
Lancaster, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2014
Primary completion: 30 Sept 2015
Completion: 30 Sept 2015
Last update posted: 22 Apr 2016
Registered enrollment: 0
Registry id: NCT02261051

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.